Gene · 10499
Papers3,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network pharmacology and experimental validation to explore the pharmacological mechanism of saw palmetto and its core ingredients in benign prostatic hyperplasia treatment. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39017714 | PubTator, text mining | PubMed |
| Flexible fluorine-thiol displacement stapled peptides with enhanced membrane penetration for the estrogen receptor/coactivator interaction. | J Biol Chem | 2024 | 39547512 | PubTator, text mining | PubMed |
| Tai/NCOA2 suppresses the Hedgehog pathway by directly targeting the transcription factor Ci/GLI. | Proc Natl Acad Sci U S A | 2024 | 39531503 | PubTator, text mining | PubMed |
| Unraveling the Molecular Landscape of Uterine Tumor Resembling Ovarian Sex Cord Tumor: Insights From A Clinicopathological, Morphologic, Immunohistochemical, and Molecular Analysis of 35 Cases. | Mod Pathol | 2024 | 39265954 | PubTator, text mining | PubMed |
| Case report: A mesenchymal chondrosarcoma with alternative HEY1::NCOA2 fusions in the sella turcica. | Pathol Oncol Res | 2024 | 39165647 | PubTator, text mining | PubMed |
| Uterine tumors mimicking ovarian sex cord tumors with rhabdoid differentiation: a clinicopathologic study of 4 cases: A case series analysis. | Medicine (Baltimore) | 2024 | 39151492 | PubTator, text mining | PubMed |
| Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" Cases. | Mod Pathol | 2024 | 39147032 | PubTator, text mining | PubMed |
| Unraveling the molecular pathogenesis of Type 2 Diabetes and its impact on female infertility: A bioinformatics and systems biology approach. | Comput Biol Med | 2024 | 39116715 | PubTator, text mining | PubMed |
| Mesomelia-synostoses syndrome: contiguous deletion syndrome, SULF1 haploinsufficiency or enhancer adoption? | Mol Cytogenet | 2024 | 38992676 | PubTator, text mining | PubMed |
| Unrevealing the multitargeted potency of 3-1-BCMIYPPA against lung cancer structural maintenance and suppression proteins through pharmacokinetics, QM-DFT, and multiscale MD simulation studies. | PLoS One | 2024 | 38905286 | PubTator, text mining | PubMed |
| Function of Steroid Receptor Coactivators in T Cells and Cancers: Implications for Cancer Immunotherapy. | Crit Rev Immunol | 2024 | 38848298 | PubTator, text mining | PubMed |
| Uncovering the WWTR1::NCOA2 Gene fusion in low-grade myoepithelial-rich neoplasm with HMGA2 expression: A case report. | Genes Chromosomes Cancer | 2024 | 38747338 | PubTator, text mining | PubMed |
| Illuminating ligand-induced dynamics in nuclear receptors through MD simulations. | Biochim Biophys Acta Gene Regul Mech | 2024 | 38614450 | PubTator, text mining | PubMed |
| FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma. | Genes Chromosomes Cancer | 2024 | 38607246 | PubTator, text mining | PubMed |
Identification of a Single Nucleotide Polymorphism of Vitamin D Receptor (VDR) and Vitamin D Binding Protein (VDBP) Gene and Its Dysregulated Pathway Through VDR-VDBP Interaction Network Analysis in Vitamin D-Deficient Infertile Females. | Cureus | 2024 | 38586664 | PubTator, text mining | PubMed |
| [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38556817 | PubTator, text mining | PubMed |
| Androgen receptor cofactors: A potential role in understanding prostate cancer. | Biomed Pharmacother | 2024 | 38417290 | PubTator, text mining | PubMed |
| Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression. | J Cancer Res Clin Oncol | 2024 | 38305916 | PubTator, text mining | PubMed |
| Biological evaluation of combinations of tyrosine kinase inhibitors with Inecalcitol as novel treatments for human chronic myeloid leukemia. | Saudi Pharm J | 2024 | 38298828 | PubTator, text mining | PubMed |
| Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases. | Medicina (Kaunas) | 2024 | 38276058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10499/papers?page=5